These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 11586035)

  • 21. [DNA ploidy and results of first line chemotherapy in ovarian cancer patients].
    Milczek T; Klasa-Mazurkiewicz D; Emerich J; Debniak J
    Ginekol Pol; 2006 Aug; 77(8):589-96. PubMed ID: 17076189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of long-term survival by flow cytometric analysis of cellular DNA content in patients with advanced ovarian cancer.
    Friedlander ML; Hedley DW; Swanson C; Russell P
    J Clin Oncol; 1988 Feb; 6(2):282-90. PubMed ID: 3276825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA flow cytometry, clinical and morphological parameters as prognostic factors for advanced malignant and borderline ovarian tumors.
    Kühn W; Kaufmann M; Feichter GE; Rummel HH; Schmid H; Heberling D
    Gynecol Oncol; 1989 Jun; 33(3):360-7. PubMed ID: 2722063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
    Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
    Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flow and image cytometric DNA ploidy, including 5c exceeding cells, of serous borderline malignant ovarian tumors. Correlation with clinicopathologic characteristics.
    Flezar MS; But I; Kavalar R; Us-Krasovec M
    Anal Quant Cytol Histol; 2003 Jun; 25(3):139-45. PubMed ID: 12882085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flow cytometric analysis of nuclear DNA content in ovarian tumors. Association of ploidy with tumor type, histologic grade, and clinical stage.
    Lage JM; Weinberg DS; Huettner PC; Mark SD
    Cancer; 1992 Jun; 69(11):2668-75. PubMed ID: 1571896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of cellular DNA content on survival in ovarian carcinoma.
    Klemi PJ; Joensuu H; Mäenpää J; Kiilholma P
    Obstet Gynecol; 1989 Aug; 74(2):200-4. PubMed ID: 2748056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of the flow cytometric DNA index in human ovarian carcinoma.
    Iversen OE
    Cancer; 1988 Mar; 61(5):971-5. PubMed ID: 3338060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flow cytometric DNA-ploidy as a prognostic indicator in oral squamous cell carcinoma.
    Wang XL; Chen RM; Wang ZS; Chen WL; Zuo LF
    Chin Med J (Engl); 1990 Jul; 103(7):572-5. PubMed ID: 2119974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flow cytometric analysis of the DNA content of adenocarcinoma of the lung, especially for patients with stage 1 disease with long term follow-up.
    Tanaka I; Masuda R; Furuhata Y; Inoue M; Fujiwara M; Takemura T
    Cancer; 1995 May; 75(10):2461-5. PubMed ID: 7736389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flow cytometric evaluation of epithelial ovarian cancer.
    Barnabei VM; Miller DS; Bauer KD; Murad TM; Rademaker AW; Lurain JR
    Am J Obstet Gynecol; 1990 Jun; 162(6):1584-90; discussion 1590-2. PubMed ID: 2360592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular DNA content and survival in advanced ovarian carcinoma.
    Pfisterer J; Kommoss F; Sauerbrei W; Renz H; du Bois A; Kiechle-Schwarz M; Pfleiderer A
    Cancer; 1994 Nov; 74(9):2509-15. PubMed ID: 7923008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA flow cytometric analysis of serous ovarian tumors of low malignant potential.
    Seidman JD; Norris HJ; Griffin JL; Hitchcock CL
    Cancer; 1993 Jun; 71(12):3947-51. PubMed ID: 8508360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is DNA aneuploidy a prognostic factor in gastric cancer?
    Omejc M; Repse S; Bracko M
    Acta Chir Hung; 1997; 36(1-4):266-9. PubMed ID: 9408370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multidrug resistance gene-1 (Pgp) expression in epithelial ovarian malignancies.
    Ozalp SS; Yalcin OT; Tanir M; Kabukcuoglu S; Etiz E
    Eur J Gynaecol Oncol; 2002; 23(4):337-40. PubMed ID: 12214739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of DNA ploidy in adenocarcinoma of the pancreas. A flow cytometric study of paraffin-embedded specimens.
    Porschen R; Remy U; Bevers G; Schauseil S; Hengels KJ; Borchard F
    Cancer; 1993 Jun; 71(12):3846-50. PubMed ID: 8508352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flow cytometric analysis of cellular DNA content in ovarian cancer.
    Hamaguchi K; Nishimura H; Miyoshi T; Miyahara K; Tateno N; Yakushiji M; Yokoyama MM
    Gynecol Oncol; 1990 May; 37(2):219-23. PubMed ID: 2344967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of nuclear DNA quantification and cyclin A expression in epithelial ovarian carcinoma.
    Yoon BS; Kim YT; Kim S; Lee CS; Kim JW; Kim JH; Kim SW; Cho NH
    Eur J Obstet Gynecol Reprod Biol; 2008 Jan; 136(1):110-5. PubMed ID: 17157431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of the DNA ploidity on survival in patients with carcinoma of papilla of Vater.
    Berczi C; Bocsi J; Lapis K; Balázs G
    Acta Chir Hung; 1997; 36(1-4):27-9. PubMed ID: 9408275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of DNA ploidy in carcinoma of prostate.
    Dejter SW; Cunningham RE; Noguchi PD; Jones RV; Moul JW; McLeod DG; Lynch JH
    Urology; 1989 May; 33(5):361-6. PubMed ID: 2711553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.